+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats



Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats



Journal of Zhejiang University. Science. B 7(8): 627-633



The prevalence of non-alcoholic fatty liver disease (NAFLD) has markedly increased. Insulin resistance has been implicated in the pathogenesis of NAFLD. This study was aimed at observing the relationship between insulin resistance and NAFLD, and evaluating the role of pioglitazone (PGZ) acting as insulin-sensitizing agents in the prevention and treatment of rat fatty liver induced by high fat feeding. The rats were separated randomly into 6 groups: model group I were fed high fat diet for 8 weeks, PGZ prevention group were given PGZ 4 mg/(kg.d) simultaneously, while control group I were fed normal food for 8 weeks; model group II were fed high fat diet for 16 weeks, PGZ treatment group were given PGZ 4 mg/(kg.d) orally simultaneous with high fat diet for 8 weeks after high fat feeding for 8 weeks, control group II were fed normal food for 16 weeks. The rats were sacrificed after 8 weeks and 16 weeks respectively. Liver weight, body weight, serum activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), tumor necrosis factor alpha (TNF-alpha), fasting blood glucose (FBG), fasting plasma insulin (FINS), HOMA (homeostasis model assessment) insulin resistance index (HOMA-IR), and the liver histology of rats of all groups were assayed. After 8 weeks, the liver in model group I showed typical steatosis, accompanied with mild to moderate lobular inflammatory cell infiltration, liver indexes and serum levels of ALT, AST, ALP, TNF-alpha were significantly increased (P<0.05) compared with control group I. Whereas, the degree of hepatic injury was attenuated in PGZ prevention group, liver indexes and serum levels of ALT, ALP were significantly decreased (P<0.05) compared with model group I. After 16 weeks, notable steatosis, and lobular inflammation were observed in model group II rat liver, while the degree of hepatic injury was attenuated in the PGZ treatment group. Liver index, serum levels of ALT, AST, ALP, FINS and HOMA-IR were significantly increased (P<0.05) in model group II compared with control group II. Whereas, in PGZ treatment group, serum levels of AST and FINS showed decreasing tendency, liver indexes, serum levels of ALT, ALP, TNF-alpha and HOMA-IR were significantly decreased compared with model group II. Insulin resistance plays a role in the pathogenesis of NAFLD in rats. Pioglitazone can attenuate insulin resistance and biochemical and histological injury in high fat-induced fatty liver in rats.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012816307

Download citation: RISBibTeXText

PMID: 16845716

DOI: 10.1631/jzus.2006.b0627


Related references

Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. Journal of Ultrasound 19(3): 183-189, 2016

The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats. Food and Function 8(2): 842-850, 2017

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD. Korean Journal of Internal Medicine 31(3): 479-487, 2016

Current biochemical studies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach: Lin Hz, Yang SQ, Chuckaree C, et al., Metformins Reverses Fatty Liver Disease in Obese Leptin-Deficient Mice, Nature Medicine 2000;6(8):9981003. American Journal of Gastroenterology 98(2): 495-499, 2003

The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. Nutrition and Metabolism 8(1): 65, 2011

Characteristics of Fecal Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients: Aconnection between Endotoxin and NAFLD. Journal of Hepatology 64(2): S189-S190, 2016

Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD. Clinical and Experimental Pharmacology and Physiology 41(9): 643-649, 2014

Pharmacological and antioxidant actions of garlic and.or onion in non-alcoholic fatty liver disease (NAFLD) in rats. Journal of the Egyptian Society of Parasitology 44(2): 295-308, 2014

The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD). Hormones 17(2): 219-229, 2018

Direct comparison of two non invasive biomarkers for the diagnosis of advanced fibrosis in patients with non alcoholic fatty liver disease (NAFLD): NAFLD score and fibrotest. 2007

A study of the prebiotic-like effects of tomato juice consumption in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). Food and Function 8(10): 3542-3552, 2017

Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD). Hepatobiliary Surgery and Nutrition 4(3): 147-151, 2015

Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet. Bmc Pediatrics 16(1): 187, 2016

Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD). Clinical Laboratory 61(10): 1409-1414, 2015

A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD. Liver International 37(8): 1209-1218, 2017